OCT 07, 2022
GCANRx Announces Submission of Phase 2 Clinical Trial Application to Treat Autism Related Spectrum Disorders
GCANRx Announces Submission of Phase 2 Clinical Trial Application to Treat Autism Related Spectrum Disorders
GCANRx Strategic Advisor Dr. Adi Aran to be Interviewed by Dr. Sanjay Gupta on CNN Cannabis Special
GCANRx Appoints Renowned Cannabinoid Researcher Dr. Adi Aran as Strategic Advisor
GCANRx Announces Initiation of Preclinical Study for Neuropsychiatric Cannabinoid Therapy
GCANRx Signs Licensing Agreement with Shaare Zedek Scientific for Innovative Neuropsychiatric Cannabinoid Therapy
GCANRx Announces Collaboration with Renowned Cannabis Research Lab
The Greater Cannabis Company Announces Relisting to OTCQB
Greater Cannabis To Present at the Benzinga Cannabis Capital Conference
Greater Cannabis Company Announces Retirement of Remaining Convertible Debt
The Greater Cannabis Company Announces Launch of Bob Ross Beauty and Cosmetics Products
Greater Cannabis Partners with Leading Beauty Brand, Cinema Secrets
Greater Cannabis Launches CBD Oral Patch Product With European Partner Symtomax
The Greater Cannabis Company Completes International Shipment of 125,000 Oral CBD Patches
The Greater Cannabis Company Inc. Announces a Material Reduction in Corporate Debt
GCAN Receives Purchase Order for 125,000 Units of its Oral Cannabis Patch from Symtomax
Greater Cannabis Company Advances CBD Study With Researchers From Israel Cannabis Research Center
Former Portugal State Secretary of Health Joins Greater Cannabis Company’s European Partner, Symtomax
The Greater Cannabis Company Expands CBD Delivery Portfolio With Newly Developed Transdermal Patch
Greater Cannabis CEO to be Interviewed Today on Yahoo Finance Live at 12:40pm EST
The Greater Cannabis Company Provides Corporate Update to Shareholders
Greater Cannabis Company Signs letter of intent (LOI) with RST, Inc.
GREATER CANNABIS COMPANY PARTNERS WITH SYMTOMAX® TO EXPAND ACROSS EUROPE, THE MIDDLE EAST AND AFRICA
Greater Cannabis CEO to be Interviewed Today By Cheddar Financial News Live From the New York Stock Exchange
GREATER CANNABIS COMPANY LICENSES CBD PATCH TECHNOLOGY TO MAJOR BRAZILIAN RETAIL PHARMACY COMPANY
Greater Cannabis Company Partners with Allume Cosmeticos To Develop New Cosmetics Line
Greater Cannabis Company Announces Expansion Into CBD Cosmetics And Beauty Market
GREATER CANNABIS TO BEGIN CLINICAL STUDY OF CBD ABSORPTION THROUGH ITS MULTIFUNCTIONAL, MULTILAYER INTRA-ORAL DRUG DELIVERY TECHNOLOGY
The Greater Cannabis Company Announces Uplisting To New Market Tier
The Greater Cannabis Company Announces Distribution Agreement With Leading Global Cannabis Company iCAN: Israel Cannabis Ltd.
The Greater Cannabis Company to Update Shareholders on Corporate Strategy and Developments of Eluting . . .
The Greater Cannabis Company Files Additional Patent to Further Protect Proprietary Cannabinoid Delivery System
The Greater Cannabis Company Appoints Dr. Hock Tan as Chairman of Scientific Advisory Board
The Greater Cannabis Company Announces Appointment of David Tavor to its Board of Directors
The Greater Cannabis Company, Inc. Acquires Cannabis Biotech Green C Corporation through a Share Exchange Agreement
Sylios Corp Update on The Greater Cannabis Company, Inc. and Additional Corporate Events
The Greater Cannabis Company to Launch the GCC Superstore on St. Patrick's Day with in Excess of 150 SKUs
Sylios Corp Announces Record Date for Spin-Off of The Greater Cannabis Company, LLC
Sylios Corp to Spin-Off its Wholly Owned Subsidiary, The Greater Cannabis Company, LLC, to Shareholders
The Greater Cannabis Company to Expand its Investment Holdings in the Medical/Recreational Marijuana Sector
Stay up to date on the latest news.
© 2023 The Greater Cannabis Company, Inc. ALL Rights Reserved